On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Institute of Cancer Research: the Royal Cancer Hospital Lbg's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€8.2M · 24 projects
- Horizon 2020€5.6M · 16 projects
- Horizon Europe€3.3M · 10 projects
Projects
50 EU-funded projects, newest first. Institute of Cancer Research: the Royal Cancer Hospital Lbg led 17 of them as coordinator. Each links to the official record.
- dIscOverNETPartner
Developing Immune Strategies to Counter tumor-immune-micrOnVironmEntal Resistance in NeuroEndocrine Tumors.
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€697ktheir share - ORFeusPartner
Decoding the dark proteome through interdisciplinary training and research
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€349ktheir share - OCTOPOD-Ph2aPartner
A Novel Phase-2a Clinical Trial for a Next-Generation Oncolytic Immunotherapy Targeting Platinum-Resistant Ovarian Cancer
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€651ktheir share - B-REDiTxCoordinator
Optimising cancer therapy scheduling through personalised mechanistic models and reinforcement learning
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€260ktheir share - EvoMG-DNPartner
Evolutionary Medical Genomics Doctoral Network
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€697ktheir share - HER-CAREPartner
Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€349ktheir share - INTERACTAssociated partner
Interdisciplinary Marie Skłodowska-Curie Action for Health
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- EVOBREASTCoordinator
Uncovering immunoediting strategies underlying malignant transformation in breast tissues
Horizon Europe · 2025–2027 · Project on CORDIS ↗
€260ktheir share - AdaptmetAssociated partner
Deconstructing adaptive evolution of metastasis
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- MONALISAAssociated partner
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
Horizon Europe · 2024–2028 · Project on CORDIS ↗
- EvometPartner
Deconstructing the evolution of metastasis
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€303ktheir share - VAGABONDPartner
Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€303ktheir share - UBIMOTIFPartner
Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€303ktheir share - EVOMETCoordinator
The rise and fall of metastatic clones under immune attack
Horizon 2020 · 2019–2021 · Project on CORDIS ↗
€225ktheir share - CANCEREVOPartner
Deciphering and predicting the evolution of cancer cell populations
Horizon 2020 · 2019–2025 · Project on CORDIS ↗
€750ktheir share - FURTHERPartner
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastasis
Horizon 2020 · 2019–2025 · Project on CORDIS ↗
€450their share - €606ktheir share
- COLOSSUSPartner
Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€295ktheir share - €273ktheir share
- DRIVEPartner
Driving next generation autophagy researchers towards translation
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€273ktheir share - ITCC-P4Partner
ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064
Horizon 2020 · 2017–2023 · Project on CORDIS ↗
€647ktheir share - REDOXCYCLECoordinator
The molecular interface between cell cycle and redox regulation
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
€236ktheir share - €632ktheir share
- EMCOP9CRLCoordinator
Structural basis of Cullin-RING ligase regulation by the COP9 signalosome
Horizon 2020 · 2015–2017 · Project on CORDIS ↗
€183ktheir share - B-CASTPartner
Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€383ktheir share - Human Rpc5Coordinator
RNA Polymerase III Rpc4/Rpc5 subcomplex and Selenocysteine tRNA transcription
Horizon 2020 · 2015–2017 · Project on CORDIS ↗
€183ktheir share - BARCODECoordinator
The use of genetic profiling to guide prostate cancer targeted screening and cancer care
FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗
€2.5Mtheir share - RESICT-PCCoordinator
Studying Resistance to Cancer Therapeutics in Prostate Cancer
FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗
€231ktheir share - CDELPCoordinator
CHD1 Deletion: Implications to Outcome and Treatment in Prostate Cancer
FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗
€231ktheir share - LIVERNCODECoordinator
Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€93ktheir share - TAMIRCRTCoordinator
Targeting microRNAs for ColoRectal Cancer Therapy
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€9ktheir share - DECIDEPartner
Decision-making within cells and differentiation entity therapies
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€285ktheir share - CELARPartner
CELAR: Automatic, multi-grained elasticity-provisioning for the Cloud
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€6ktheir share - CTCTRAPPartner
Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€636ktheir share - ICRMYELOMACoordinator
Sequence of Mutational Events and Sub-clonal Architecture in Plasma Cell Myeloma
FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗
€209ktheir share - QUIC-CONCEPTPartner
QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy
FP7 (2007 to 2013) · 2011–2018 · Project on CORDIS ↗
€561ktheir share - ECNIS2Partner
ECNIS2: towards ECNIS Centre for Research and Education on Cancer, Environment and Food
FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗
- Melanoma InvasionCoordinator
Molecular mechanisms of melanoma invasion
FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗
€210ktheir share - pARylomeCoordinator
pARylation-mediated regulation of cancer pathways
FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗
€30ktheir share - DDRESPONSEPartner
The DNA damage response and breast cancer
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€686ktheir share
Show 10 more projects
- SYSCOLPartner
Systems Biology of Colorectal Cancer
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€853ktheir share - EUROCANPLATFORMPartner
A European Platform for Translational Cancer Research
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€226ktheir share - BASISPartner
Breast Cancer Somatic Genetics Study
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€91ktheir share - HER2 MAMMARYSTEMCELLCoordinator
The influence of Her2 status on mammary stem/progenitor cells
FP7 (2007 to 2013) · 2009–2011 · Project on CORDIS ↗
€172ktheir share - SAGHEPartner
Safety and Appropriateness of Growth hormone treatments in Europe
FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗
€152ktheir share - COGSPartner
Collaborative Oncological Gene-environment Study
FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗
€601ktheir share - EPOCPartner
European Paediatric Oncology Off-Patent Medicines Consortium
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
- SYNTHLE BRCACoordinator
Synthetic lethality approaches to BRCA-associated cancer
FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗
€169ktheir share - 03KPartner
Oral Off-patent Oncology Drugs for Kids
FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗
€54ktheir share - BASAL BREAST CANCERCoordinator
Characterization of myoepithelial differentiation in basal-like breast cancer cells
FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗
€169ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 10 shared projects
- Karolinska InstitutetSweden · 7 shared projects
- Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek ZiekenhuisNetherlands · 7 shared projects
- King'S College LondonUnited Kingdom · 6 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 6 shared projects
- Institut Gustave RoussyFrance · 6 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 5 shared projects
- Deutsches Krebsforschungszentrum HeidelbergGermany · 5 shared projects
- Eidgenoessische Technische Hochschule ZuerichSwitzerland · 4 shared projects
- Helsingin YliopistoFinland · 4 shared projects
- European Molecular Biology LaboratoryGermany · 4 shared projects
- Charite - Universitaetsmedizin BerlinGermany · 4 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 4 shared projects
- Universitat BaselSwitzerland · 4 shared projects
- Institut CurieFrance · 4 shared projects
- Prinses Maxima Centrum Voor Kinderoncologie BVNetherlands · 4 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- RNA
- antibiotic resistance
- basal cells
- biochemistry
- breast cancer
- cell biology
- cell signaling
- colorectal cancer
- comets
- computational science
- crystallography
- data science
- databases
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
